Tiverton Asset Management’s Ascendis Pharma A/S ASND Stock Holding History

Tiverton Asset Management’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$2.3M	Buy	23,837 +2,853	+14%	+$318K	0.08%	192
2019 Q2	$2.42M	Buy	20,984 +1,389	+7%	+$166K	0.09%	181
2019 Q1	$2.31M	Sell	19,595 -7,128	-27%	-$624K	0.1%	162
2018 Q4	$1.67M	Sell	26,723 -18,993	-42%	-$1.19M	0.1%	134
2018 Q3	$3.24M	Buy	45,716 +1,877	+4%	+$129K	0.16%	107
2018 Q2	$2.92M	Buy	43,839 +1,695	+4%	+$111K	0.15%	116
2018 Q1	$2.76M	Buy	+42,144	New	+$2.37M	0.19%	104

Other funds holding ASND

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Tiverton Asset Management's ASND Position: Q3 2019 in Review

Tiverton Asset Management increased its Ascendis Pharma A/S (ASND) stake by 14% in Q3 2019, buying an estimated $318K and bringing the position to 23,837 shares worth $2.3M. The position accounts for 0.08% of the portfolio, ranked #192.

Tiverton Asset Management first reported a position in ASND in Q1 2018 and has held it in 7 quarters since. The position peaked at $3.24M in Q3 2018. 129 funds tracked by Wall St. Rank hold ASND as of Q3 2019.

Tiverton Asset Management held 23,837 shares of Ascendis Pharma A/S worth $2.3M as of Q3 2019.
Tiverton Asset Management bought 2,853 Ascendis Pharma A/S shares in Q3 2019, an estimated $318K.
Ascendis Pharma A/S made up 0.08% of Tiverton Asset Management's portfolio in Q3 2019, its #192 holding.
Tiverton Asset Management first reported a position in Ascendis Pharma A/S in Q1 2018 and has held it in 7 quarters since.
Tiverton Asset Management's Ascendis Pharma A/S position peaked at $3.24M in Q3 2018.
129 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q3 2019.

Based on Tiverton Asset Management's 13F filing for Q3 2019, filed 13 Nov 2019.